Presently, clinical trials involving the anti-SIRPα monoclonal antibody BI 770371, evorpacept, and the SIRPα-4-1BBL fusion protein DSP107, among many others, are underway across various other cancer types [142, 143]. This evidence concerns the gene SIRPA and cancer.